Translational Sciences is a biotechnology company that develops therapeutics for treating acute thrombotic cardiovascular diseases and ischemic stroke. It offers TS23, a blood clot-dissolving antibody; M9i, to treat acute ischemia and inflammation; and Pi, to stop surgical and traumatic hemorrhage.